Avidity Biosciences, Inc. (RNA): Wutah pendapatan triwulanan

RNA (Avidity Biosciences Inc) - tandha merek perusahaan

The quarterly revenue chart on GURU.Markets confirms the transparency of the RNA platform management, where the parameter value equals 299.20. Anticipation of the final trial results for myopathy drugs is driving investor interest, despite the absence of current sales. High barriers to entry in genetic engineering and strict regulatory oversight solidify the status of Avidity Biosciences (RNA) as a monopolist due to its patents.

RNA (Avidity Biosciences Inc) riwayat Tingkat wutah dodolan sajrone kuartal saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Avidity Biosciences, Inc. (RNA)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis wiwitan perusahaan:Avidity Biosciences Inc (RNA)
Produk seri aviditybiosciences.com

For Avidity Biosciences (RNA), which is scaling its portfolio of RNA-based therapies for muscle pathologies, this indicator serves as a leading signal of the business's commercial readiness. The metric measures quarter-over-quarter revenue growth rates with daily updates, allowing the quarterly revenue change indicator to timely identify expansion slowdowns and optimize the portfolio prior to the publication of official financial reports.

Pesaing utama

TEM - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal qiagen.com QGEN|IONS: Wutah pendapatan triwulanan|Repligen Corp - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal CRISPR Therapeutics|WGS - Owah-owahan pendapatan dibandhingake kuartal kepungkur|Wutah pendapatan triwulanan RARE|Owah-owahan dodolan kuartal marang kuartal BEAM|Wutah pendapatan triwulanan SRPT (Sarepta Corp)|TWST - Wutah dodolan triwulanan|TXG: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Intellia Therapeutics|STOK: Wutah pendapatan triwulanan|BLFS - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan WVE|MAZE: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Sionna Corp (SION)|Tingkat wutah dodolan sajrone kuartal Prime Medicine Bio|Wutah pendapatan triwulanan TSHA (Taysha Gene Therapies Inc)|Wutah pendapatan triwulanan uniqure.com QURE|MeiraGTx Holdings - Wutah pendapatan triwulanan|RGNX - Wutah pendapatan triwulanan|SLDB (Solid Corp) - Wutah dodolan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Ocugen Corp OCGN|PACB (Pacific Biosciences) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BNTC|Wutah pendapatan triwulanan DSGN|Wutah dodolan triwulanan Rocket Pharma RCKT|Tingkat wutah dodolan sajrone kuartal FDMT|Wutah pendapatan triwulanan Lexeo Therapeutics LXEO|KRRO - Wutah pendapatan kuartal marang kuartal|EDIT (Editas Medicine, Inc.) - Wutah dodolan kuartal marang kuartal|SLN: Wutah pendapatan triwulanan|ProQR - Tambahing pendapatan triwulanan|CDXS (Codexis) - Wutah pendapatan triwulanan|Sangamo (SGMO) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan NAUT|Wutah dodolan triwulanan Metagenomi, Inc. MGX|Wutah pendapatan kuartal marang kuartal Precision BioSciences DTIL|Tambahing pendapatan triwulanan GBIO|BOLD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Wutah pendapatan kuartal marang kuartal|RXi Pharmaceuticals - Tambahing pendapatan triwulanan|MBIO (Mustang Bio) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal RNAZ (transcodetherapeutics.com)|Wutah pendapatan kuartal marang kuartal Bionano (BNGO)|Applied DNA Sciences - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Tingkat wutah pendapatan sajrone kuartal|omegatherapeutics.com - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Singular Genomics Systems Inc (OMIC)|RGLS: Wutah pendapatan triwulanan|Syros Pharmaceuticals, Inc (SYRS) - Wutah pendapatan triwulanan|TBIO (telesisbio.com) - Wutah pendapatan triwulanan|TCON: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Unity Biotechnology, Inc (UBX)